Background: Since access to polysomnography is often limited, overnight pulse oximetry (OPO) is often used as an alternative despite its lower sensitivity. OPO can be an effective screening tool for sleep-disordered breathing (SDB), potentially indicating the presence of obstructive sleep apnea (OSA). OPO is also required for organizing postoperative monitoring following adenotonsillectomy. The Pediatric Sleep Questionnaire (PSQ) is a validated 22-item questionnaire that assesses OSA symptoms, of which the first six items report obstructive symptoms (obstructive subscale). Our study aims to determine the correlation between OPO and PSQ results and to evaluate if this questionnaire can be used to prioritize OPO for children suspected of OSA.
Methods: We conducted a retrospective, single-center study in a pediatric tertiary hospital involving 100 consecutive children. Participants were included if they were 2 years and older, had clinical suspicion of OSA, a completed PSQ, and a recent OPO result.
Results: The total PSQ score and the obstructive PSQ subscale have respective sensitivities of 80.4 % and 83.8 % for predicting SDB suggested by OPO. The sensitivity of the obstructive subscale increases to 90.9 % in children with adenotonsillar hypertrophy. However, the PSQ score isn't a reliable predictor of the severity of OSA as determined by OPO. The presence of comorbidities in children does not influence the correlation between the PSQ and OPO results.
Conclusion: The obstructive PSQ subscale is a quick, easy, and sensitive tool for predicting OSA diagnosed by OPO, particularly when there is adenotonsillar hypertrophy. The PSQ can prioritize children with high scores for OPO.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijporl.2025.112245 | DOI Listing |
The reaction of a hydrated cobalt(II) perchlorate salt with the rigid tripodal ligand, tris(3,5-dimethylpyrazolyl) phosphine oxide, (O)P(3,5-DMPz)3, results in selective in situ hydrolysis of a P‒N bond affording a neutral mononuclear Co(II) complex, [Co{(O)P(O)(3,5-DMP)2}2] (1Co(II)). The X-ray crystal structure of 1Co(II) shows that it is formed by the coordination of two N2O-tripodal (O)P(O)(3,5-DMPz)2 ligands, leading to a CoIIN4O2 coordination sphere with an elongated pseudo-trigonal antiprismatic geometry. The analysis of the dc magnetic data revealed that this compound shows a strong easy-axis magnetic anisotropy with D = ‒45.
View Article and Find Full Text PDFOphthalmic Physiol Opt
March 2025
School of Optometry, Indiana University, Indiana, USA.
Purpose: Part 1 of the study investigated image quality associated with oblique incidence of light on a multisegment lens (Hoya MiyoSmart) intended to treat myopia development. Part 2 investigates power corrections associated with oblique incidence.
Methods: Modelling and ray tracing were carried out with lenses of -4 D distance power and, to a lesser extent, +0.
Ophthalmic Physiol Opt
March 2025
Centre for Eye Research Ireland, Environmental Sustainability and Health Institute, Technological University Dublin, Dublin, Ireland.
Out-of-sequence (OOS) allocation, the process by which organ procurement organizations (OPOs) can deviate from standard rank lists of potential recipients to expeditiously allocate deceased-donor kidneys, is rising in the U.S. We aimed to determine whether current OPO reporting practices obscure the extent of OOS allocation.
View Article and Find Full Text PDFOphthalmic Physiol Opt
March 2025
Centre for Vision and Eye Research, Contact Lens and Visual Optics Laboratory, Queensland University of Technology, Brisbane, Queensland, Australia.
Purpose: Low concentration atropine is an effective treatment to slow myopia progression and axial elongation and also reduces accommodation. On-axis ocular dimensions of the eye change during accommodation; hence, this study aimed to quantify the effect of 0.025% atropine eye drops on accommodation-induced changes in ocular biometry.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!